Modified Salmonella Revs Immune Response, Combats Tumors in Mice

When coated with positively charged particles, the bacteria shuttled antigens out of tumors and activated the immune system, a study finds.

Written byNatalia Mesa, PhD
| 5 min read
Salmonella (pink) invading a human epithelial cell (yellow)
Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

As tumors grow, they skillfully evade the body’s immune response. Cancer cells multiply quickly, forming a dense mass of tissue and vasculature that becomes increasingly difficult for immune cells to infiltrate, and they begin to pump out molecules that suppress immune cell function.

In some cancer patients, just outside the tumor, many immune cells function normally. Dendritic cells capture antigens on the tumor’s surface and launch an immune cascade, marking cancer cells for destructionbut often not at the rate necessary to halt tumor growth.

In a paper published January 20 in Nature Biomedical Engineering, scientists report using a combination of modified Salmonella bacteria and radiation to enhance the body’s natural immune response against tumors in mice. The researchers injected the Salmonella into tumors to capture antigens and shuttle them out, making the antigens accessible to immune cells.

“I thought the study was really innovative,” Andrew Redenti, a graduate student in ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • A black and white headshot

    As she was completing her graduate thesis on the neuroscience of vision, Natalia found that she loved to talk to other people about how science impacts them. This passion led Natalia to take up writing and science communication, and she has contributed to outlets including Scientific American and the Broad Institute. Natalia completed her PhD in neuroscience at the University of Washington and graduated from Cornell University with a bachelor’s degree in biological sciences. She was previously an intern at The Scientist, and currently freelances from her home in Seattle. 

    View Full Profile
Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Skip the Wait for Protein Stability Data with Aunty

Skip the Wait for Protein Stability Data with Aunty

Unchained Labs

Products

Sino Biological Logo

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughout Kinase Inhibitor Screening

SPT Labtech Logo

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT's firefly platform

nuclera logo

Nuclera eProtein Discovery System installed at leading Universities in Taiwan

Brandtech Logo

BRANDTECH Scientific Introduces the Transferpette® pro Micropipette: A New Twist on Comfort and Control